Misconduct policies in high-impact biomedical journals

Area of Science:

• Biomedical research ethics
• Scholarly publishing standards
• Scientific integrity

Background:

• The adoption and content of research misconduct policies among influential biomedical journals remain unclear.
• This study aimed to assess the prevalence and specifics of misconduct policies and handling procedures in leading biomedical journals.

Purpose of the Study:

• To evaluate the extent to which high-impact biomedical journals define research misconduct.
• To determine the prevalence of policies addressing specific misconduct types (plagiarism, fabrication, falsification, duplication, image manipulation).
• To examine the availability of procedures for responding to misconduct allegations and the use of plagiarism-checking services.

Main Methods:

• A cross-sectional study analyzed misconduct policies of 399 high-impact biomedical journals across 27 categories.
• Journal websites were systematically reviewed for information pertaining to research misconduct policies and procedures.
• Data collection occurred in December 2011, focusing on explicit policy definitions and response mechanisms.

Main Results:

• Only 35.1% of journals provided explicit definitions of research misconduct.
• Plagiarism (56.1%) and duplication (60.7%) were the most frequently defined misconduct types; image manipulation was defined by 38.6%.
• Less than half (44.9%) of journals detailed procedures for responding to misconduct, such as retraction (30.8%) or expression of concern (16.3%).

Conclusions:

• A significant gap exists in the public availability of clear misconduct definitions and response procedures in top-tier biomedical journals.
• Journals adhering to policies from established bodies (e.g., editors' associations, Office of Research Integrity) demonstrated higher policy implementation.
• Standardization of misconduct policies globally by journals and publishers is recommended to enhance public trust in the biomedical literature.